Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-20

Clinical Trial Update: Continuous Interscalene Block vs Liposomal Bupivacaine After Proximal Humerus Fracture Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing continuous interscalene block to liposomal bupivacaine after proximal humerus fracture surgery is ongoing; no results or status are av…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)
  • continuous interscalene block (continuous interscalene block)

Snippet

Sponsor: The University of Hong Kong | Conditions: Shoulder Fractures | Phase 3 | Status: UNKNOWN